|
全民健康保險藥品給付規定 / 健保碼及健保價 |
|
See related Tygacil inj[老虎黴素 凍晶注射劑] information |
|
|
|
製造商 |
Pfizer |
|
代理/經銷商 |
Pfizer |
|
成份 |
Tigecycline |
|
適應症 |
Treatment of complicated skin & skin structure infections, complicated intra-abdominal infections & community-acquired pneumonia caused by susceptible microorganisms sensitive to tigecycline. |
|
用量 |
Adult ≥ 18 years Initially, 100 mg by IV infusion over approx 30-60 mins 12 hrly, followed by 50 mg 12 hrly. Complicated skin & skin structure infections or complicated intra-abdominal infections Duration of treatment: 5-14 days. Community-acquired pneumonia 7-14 days. |
|
過量 |
View Tygacil[老虎黴素] overdosage for action to be taken in the event of an overdose. |
|
美國食品藥物管理局之懷孕等級 |
Category D: There is positive evidence of human foetal risk, but the benefits from use in pregnant women may be acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious disease for which safer drugs cannot be used or are ineffective). |
|
禁忌 |
Hypersensitivity. |
|
注意事項 |
Hypersensitivity to tetracyclines; severe hepatic impairment; may cause permanent discoloration of the teeth if used during tooth development; pseudomembranous colitis; use in complicated intra-abdominal infections secondary to clinically apparent intestinal perforation; monitor patient for overgrowth of non-susceptible organisms, including fungi. Pregnancy & lactation. |
|
不良反應 |
Abdominal pain, abscess, asthenia, back pain, fever, headache, infection, pain; HTN, hypotension, phlebitis; constipation, diarrhea, dyspepsia, nausea, vomiting; anemia, leukocytosis, thrombocythemia; increased alkaline phosphatase/amylase/BUN/lactic dehydrogenase/SGOT/SGPT, bilirubinemia, abnormal healing, hyperglycemia, hypokalemia, hypoproteinemia, peripheral edema; dizziness, insomnia; increased cough, dyspnea, pulmonary physical finding; pruritus, rash, sweating; inj site reactions.
View ADR Monitoring Website[參閱藥物不良反應監測表格] |
|
交互作用 |
Monitor prothrombin time during coadministration with warfarin. May reduce effectiveness of OCs.
View more drug interactions with Tygacil[老虎黴素] |
|
使用上注意 |
For caution against possible variation of physical aspect of medicine... click to view Tygacil[老虎黴素] detailed prescribing infomation |
|
儲存 |
View Tygacil[老虎黴素] storage conditions for details to ensure optimal shelf-life. |
|
描述 |
View Tygacil[老虎黴素] description for details of the chemical structure and excipients (inactive components). |
|
作用 |
View Tygacil[老虎黴素] mechanism of action for pharmacodynamics and pharmacokinetics details. |
|
本商品之市售規格 |
|
|
|
Manufacturer: |
Pfizer |
|
Distributor: |
Pfizer |
|
 |
|
|
